Product Details

Esomeprazole & Domperidone Capsules

Esomeprazole & Domperidone Capsules

Product Name : Esomeprazole & Domperidone Capsules
Brand Name : VERESO-D
Available Strength : 40mg + 30mg
Packing : 10 x 10 Capsules
Pack Insert/Leaflet : According To Your Needs
Get Inquire

Vereso-D Capsules combine a proton pump inhibitor with a prokinetic agent for the comprehensive management of gastroesophageal reflux and related motility disorders. Specifically, each capsule delivers Esomeprazole Magnesium (as enteric-coated pellets) equivalent to 40mg Esomeprazole together with 30mg Domperidone. As a result, it offers combined acid suppression and improved gastric motility in a single formulation.

The capsules combine:

  • Esomeprazole Magnesium IP (as enteric-coated pellets, equivalent to Esomeprazole 40mg) – A proton pump inhibitor that irreversibly blocks the H+/K+-ATPase enzyme in gastric parietal cells. Consequently, it suppresses gastric acid secretion, relieving symptoms of acid reflux and supporting healing of the oesophageal lining. The enteric-coated pellet formulation protects the active ingredient from degradation by stomach acid before absorption.
  • Domperidone IP (30mg) – A prokinetic agent and dopamine D2 receptor antagonist that enhances gastric motility and accelerates gastric emptying. As a result, it complements acid suppression by addressing the underlying motility component of reflux, nausea, and bloating.

Physicians prescribe Vereso-D for the management of gastroesophageal reflux disease (GERD) accompanied by symptoms of delayed gastric emptying, nausea, bloating, or functional dyspepsia. In addition, its combined mechanism addresses both acid-related and motility-related components of upper gastrointestinal symptoms. Because of this profile, Vereso-D suits gastroenterology and general practice settings managing complex reflux and dyspeptic conditions.

Key Features:

  • Overall, this combination formulation guarantees pharmaceutical-grade purity across both actives
  • Additionally, the dual-mechanism formula addresses both acid suppression and gastric motility
  • Furthermore, the enteric-coated pellet technology protects Esomeprazole from premature breakdown
  • Notably, each capsule delivers precise, validated dosage accuracy at 40mg + 30mg
  • Beyond that, rigorous quality testing backs every stage of manufacturing
  • Ultimately, a reliable supply chain suits bulk distribution to hospitals, clinics, and pharmacies

Quality you can trust,
care you can rely on.

WHO-GMP Certified Stringent Quality Control Global Standards